PCIA
Prime Capital Investment Advisors’s iShares Biotechnology ETF IBB Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.26M | Sell |
9,927
-10,355
| -51% | -$1.31M | 0.02% | 429 |
|
2025
Q1 | $2.59M | Buy |
20,282
+2,806
| +16% | +$359K | 0.03% | 318 |
|
2024
Q4 | $2.31M | Sell |
17,476
-833
| -5% | -$110K | 0.03% | 286 |
|
2024
Q3 | $2.67M | Sell |
18,309
-462
| -2% | -$67.3K | 0.04% | 273 |
|
2024
Q2 | $2.58M | Sell |
18,771
-1,463
| -7% | -$201K | 0.04% | 279 |
|
2024
Q1 | $2.78M | Sell |
20,234
-33,675
| -62% | -$4.62M | 0.04% | 290 |
|
2023
Q4 | $7.32M | Buy |
53,909
+15,019
| +39% | +$2.04M | 0.11% | 155 |
|
2023
Q3 | $4.76M | Buy |
38,890
+22,374
| +135% | +$2.74M | 0.1% | 161 |
|
2023
Q2 | $2.1M | Buy |
16,516
+10,443
| +172% | +$1.33M | 0.04% | 253 |
|
2023
Q1 | $784K | Sell |
6,073
-12,457
| -67% | -$1.61M | 0.03% | 280 |
|
2022
Q4 | $2.43M | Buy |
18,530
+16,185
| +690% | +$2.12M | 0.09% | 156 |
|
2022
Q3 | $274K | Sell |
2,345
-22,021
| -90% | -$2.57M | 0.02% | 325 |
|
2022
Q2 | $2.87M | Sell |
24,366
-10,292
| -30% | -$1.21M | 0.17% | 103 |
|
2022
Q1 | $5.29M | Hold |
34,658
| – | – | 0.29% | 68 |
|
2021
Q4 | $5.29M | Buy |
34,658
+31,761
| +1,096% | +$4.85M | 0.28% | 72 |
|
2021
Q3 | $468K | Sell |
2,897
-852
| -23% | -$138K | 0.03% | 220 |
|
2021
Q2 | $614K | Buy |
3,749
+739
| +25% | +$121K | 0.04% | 229 |
|
2021
Q1 | $453K | Sell |
3,010
-30,341
| -91% | -$4.57M | 0.03% | 198 |
|
2020
Q4 | $5.05M | Buy |
33,351
+5,044
| +18% | +$764K | 0.39% | 39 |
|
2020
Q3 | $3.83M | Buy |
28,307
+4,652
| +20% | +$630K | 0.32% | 56 |
|
2020
Q2 | $3.23M | Buy |
23,655
+4,615
| +24% | +$631K | 0.3% | 66 |
|
2020
Q1 | $2.05M | Buy |
19,040
+7,965
| +72% | +$858K | 0.24% | 76 |
|
2019
Q4 | $1.34M | Buy |
+11,075
| New | +$1.34M | 0.15% | 119 |
|
2018
Q3 | – | Sell |
-6
| Closed | -$1K | – | 301 |
|
2018
Q2 | $1K | Buy |
+6
| New | +$1K | ﹤0.01% | 342 |
|